2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.
Over the past 20-years, there has been an increased focus on the use of newer biologic medication in people with severe asthma that is not controlled with usual asthma medication.
The start of a new year is an ideal time to support people to consider small ways to begin working towards a healthy lifestyle.
The webinar will be held on Wednesday 15th January 2025 at 19:00 for 30 minutes.
This webinar featured short presentations and discussions from our amazing and vastly experienced panel: Carol Stonham, Kevin Gruffydd-Jones, Deborah Leese, Helena Cummings and Darush Attar-Zadeh, chaired by our Executive Vice-Chair Ren Lawlor.
New BTS/NICE/SIGN Guideline on Asthma: diagnosis, monitoring and chronic asthma management 2024Today (27th November) the National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and Scottish Intercollegi
Joining Ren Lawlor (PCRS Executive Vice-Chair and Advanced Nurse Practitioner) in this PCRS podcast episode is Dr Steve Holmes (GP and PCRS Committee Member).
The webinar will be held on Monday 2nd December 2024 at 13:00 for 60 minutes and will feature short presentations and discussions from our amazing and vastly experienced panel: Carol Stonham, Kevin Gruffydd-Jones, Deborah Leese, Helena Cummings and Darush Attar-Zadeh
After a short break the In Conversation webinar series is back and for October we were joined by Professor Tom Wilkinson, who is the National Respiratory Audit Programme (NRAP) Clinical Lead (among many other things including Professor of Respiratory Medicine at University of Southampton
The In Conversation webinar series is back and for October we will be joined by Professor Tom Wilkinson, who is the National Respiratory Audit Programme (NRAP) Clinical Lead (among many other things including Professor of Respiratory Medicine at University of Southampton).
Maintenance and reliever therapy (MART) is a combined treatment system for asthma where a single, combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Let's be MART for asthma.
Now is the time to make MART moves for asthma.
Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Be proactive, not reactive.